Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester)
Chemical Formula | C??H??N?O??·HPF? |
Chemical Name | 1,4,7,10-Tetraazacyclododecane-1,4,7-tris-tert-butyl acetate-10-(N-a-Fmoc-N-e-acetamido-L-lysine) |
FW (weight) | 1069.1 |
CAS Number | 479081-06-6 |
Purity | ≥ 94% |
結(jié)構(gòu)式：
供應(yīng)商：西安凱新生物科技有限公司
電 話 (e)：請(qǐng)點(diǎn)擊展臺(tái)進(jìn)入查看
()：請(qǐng)點(diǎn)擊展臺(tái)進(jìn)入查看
| 美國(guó)Macrocyclics公司大環(huán)配體試劑 | |
| Bifunctional ligands雙功能配體 | |
| Bifunctional ligands are chelating agents that also possess a reactive site for covalent attachment to bio-targeting vectors such as antibodies, peptide and proteins. They are widely used in nuclear medicine, MRI, and optical imaging applications. |
| p-NO2-Bn-Cyclen | B-110 |
| p-NO2-Bn-DOTA | B-199 |
| p-NH2-Bn-DOTA | B-200 |
| p-NH2-Bn-DOTA-tetra(t-Bu-ester) | B-201 |
| p-SCN-Bn-DOTA | B-205 |
| DOTA-tris (t-Bu ester) | B-260 |
| DOTA-mono-NHS-tris(t-Bu ester) | B-270 |
| Maleimido-mono-amide-DOTA-tris (t-Bu ester) | B-271 |
| Maleimido-mono-amide-DOTA | B-272 |
| Fmoc-L-Lys-mono-amide-DOTA-tris(t-Bu ester) | B-275 |
| 2-Aminoethyl-mono-amide-DOTA-tris(t-Bu ester) | B-277 |
| Azido-mono-amide-DOTA-tris(t-butyl ester) | B-278 |
| DOTA-NHS-ester | B-280 |
| Azido-mono-amide-DOTA | B-288 |
| p-NH2-Bn-DTPA | B-300 |
| p-NH2-Bn-DTPA-penta (t-Bu ester) | B-301 |
| p-SCN-Bn-DTPA | B-305 |
| p-NH2-CHX-A"-DTPA | B-351 |
| CHX-A''-DTPA | B-355 |
| DTPA-tetra (t-Bu ester) | B-365 |
| Maleimido-mono-amide-DTPA | B-372 |
| p-NH2-Bn-PCTA | B-401 |
| p-SCN-Bn-PCTA | B-405 |
| p-NH2-Bn-oxo-DO3A | B-501 |
| p-SCN-Bn-oxo-DO3A | B-505 |
| p-NH2-Bn-NOTA | B-601 |
| p-SCN-Bn-NOTA | B-605 |
| Desferrioxamine-p-SCN | B-705 |
| DOTA-Biotin-Sarcosine | C-100 |
| Samplet Pack- Bifunctionals | S-100 |
| Macrocyclic ligands大環(huán)配體 | |
| We offer a wide range of aza-macrocyles that are useful for selective metal ion complexation. These include non-functionalized ligands as well as N-functionalized analogs with variable ligating pendant substituents. |
| Cyclen | M-100 |
| Cyclam | M-110 |
| DO2A | M-125 |
| DOTA | M-140 |
| DOTP | M-150 |
| DOTMA | M-160 |
| TETA | M-170 |
| DOTAM | M-180 |
| DiAmSar | M-190 |
| CB-Cyclam | M-200 |
| CB-TE2A | M-220 |
| NOTA | M-600 |
| TACN | M-90 |
| MRI Contrast Agents核磁共振成像造影劑 | |
| Magnetic Resonance Imaging (MRI) contrast agents are a group of contrast media used to improve the visibility of internal body structures using MRI. We offer agents that are being developed for the ability to measure physiological properties such as pH and temperature. |
| Tm-DOTA | M-145 |
| Gd-DOTA | M-147 |
| Tm[DOTP]5- | M-155 |
| Tm-DOTMA | M-165 |
| Eu-DOTA-4AmC | M-503 |
| Reactive Intermediates有機(jī)反應(yīng)活性中間體 | |
| Reactive aza-macrocyclic intermediates are used as building blocks for multi-step syntheses. These compounds utilize protected functionality that permits subsequent reactions to be performed in high yield and high purity. |
| BisCBZ-Cyclen | I-121 |
| TrisBOC-Cyclen | I-131 |
| DO2A-t-Bu-ester | M-120 |
| DO3A-t-Bu-ester | M-130 |
以上資料源于西安凱新生物科技有限公司
如有其他信息或產(chǎn)品信息咨詢(xún)請(qǐng)致電我們
西安凱新生物科技有限公司
